Annovis Bio stock dips after pricing $21M securities offering
Annovis Bio (NYSE:ANVS) shares fell around 19% premarket on Monday after the company priced a securities offering to raise $21M. The sale comprises 5.25M shares of common stock and warrants to ...
Annovis Bio Prices Offering Of 5.25 Mln Shares At $4/Share, Stock Falls In Pre-Market
Late-stage clinical drug platform company Annovis Bio, Inc. (ANVS), Monday announced the pricing of 5.25 million common stock and ...
Annovis Bio sets terms for $21 million public offering
MALVERN, Pa. - Annovis Bio, Inc. (NYSE: ANVS), a clinical-stage pharmaceutical company with a market capitalization of $67 million specializing in the development of treatments for neurodegenerative ...
Annovis Bio announces pricing of $21M offering of stock, warrants
Annovis Bio (ANVS) announced the pricing of an underwritten public offering of 5.25M shares of common stock and warrants to purchase 5,250,000 ...
Yahoo Finance2d
Annovis Bio, Inc. Announces Proposed Public Offering
Annovis Bio, Inc. MALVERN, Pa., Jan. 31, 2025 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company ...
Yahoo Finance20d
Annovis Granted U.S. Patent for Treatment and Prevention of Acute Brain or Nerve Injuries Securing Global Protection
Annovis Bio, Inc. MALVERN, Pa, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative ...
Mena FN2d
Annovis Bio, Inc. Announces Proposed Public Offering
(MENAFN- GlobeNewsWire - Nasdaq) MALVERN, Pa., Jan. 31, 2025 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the“Company”), a ...
Yahoo Finance2d
Annovis Bio, Inc. Announces Proposed Public Offering
MALVERN, Pa., Jan. 31, 2025 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies ...